211 related articles for article (PubMed ID: 6153283)
21. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
22. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
23. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
24. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
25. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
26. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
28. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
29. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
Chance WT; von Meyenfeldt M; Fischer JE
Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
[TBL] [Abstract][Full Text] [Related]
30. Increased behavioural response to intrathecal substance P after intracerebroventricular 5,7-dihydroxytryptamine but not after p-chlorophenylalanine administration.
Eide PK; Hole K; Broch OJ
Acta Physiol Scand; 1988 Mar; 132(3):419-23. PubMed ID: 2465667
[TBL] [Abstract][Full Text] [Related]
31. Tolerance to the serotonin 5-HT1 agonist RU 24969 and effects on dopaminergic behaviour.
Oberlander C; Demassey Y; Verdu A; Van de Velde D; Bardelay C
Eur J Pharmacol; 1987 Jul; 139(2):205-14. PubMed ID: 2443369
[TBL] [Abstract][Full Text] [Related]
32. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
Rodríguez FD; Rodríguez RE
Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
[TBL] [Abstract][Full Text] [Related]
34. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
Paris JM; Mitsushio H; Lorens SA
Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
[TBL] [Abstract][Full Text] [Related]
35. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
36. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
Ortmann R; Martin S; Waldmeier PC
Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
[TBL] [Abstract][Full Text] [Related]
37. Rostral hypothalamic microinfusions of 5,7 dihydroxytryptamine produce anatomically and neurochemically selective depletions of hippocampal serotonin and increase the influence of estrogen and food deprivation on locomotor activity.
Waldbillig RJ; Weider GE; Clemmons RM; Bartness TJ
Brain Res; 1985 Nov; 347(1):149-53. PubMed ID: 4052795
[TBL] [Abstract][Full Text] [Related]
38. Experimentally induced supersensitivity of neocortical neurons to microiontophoretically administered serotonin.
Olpe HR; Ortmann R; Fehr B; Waldmeier PC
Brain Res; 1981 Nov; 224(2):367-74. PubMed ID: 6169411
[TBL] [Abstract][Full Text] [Related]
39. The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding.
Nazar M; Siemiatkowski M; Bidziński A; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
J Neural Transm (Vienna); 1999; 106(5-6):355-68. PubMed ID: 10443543
[TBL] [Abstract][Full Text] [Related]
40. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
